Amplification of signal transduction capacity and down-regulation by drugs

Advances in Enzyme Regulation

Volumn 39, Issue 1, 1999, Pages 51-66

  Weber, George ^a   Shen, Fei ^a   Yang, Hongyuan ^a   Prajda, Noemi ^b   Li, Wei ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Meditest Ltd   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; GENISTEIN; INOSITOL PHOSPHATE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE C; QUERCETIN; RIBAVIRIN; TAMOXIFEN; TIAZOFURIN;

ANIMAL; BREAST TUMOR; CANCER CELL CULTURE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; COLON TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TUMOR; METABOLISM; NEOPLASM; OVARY TUMOR; RAT; SIGNAL TRANSDUCTION;

EID: 0032850657     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(98)00027-2     Document Type: Conference Paper

References (32)

1. G. WEBER, Enzymology of the cancer cell. New Engl. J. Med. 296, 486-493 and 541-551 (1977).
2. G. WEBER, Biochemical strategy of cancer cells and the design of chemotherapy. G. H. A. Clowes Memorial Lecture, Cancer Res. 43, 3466-3542 (1983).
3. G. WEBER, F. SHEN, W. LI, N. PRAJDA, L. HULLAN and H. YANG, Novel advances in the regulation of signal transduction activity, Advan. Enzyme Regul. 38, 49-62 (1998).
4. N. PRAJDA, S. ECKHARDT, Z. SUBA and K. LAPIS, Biochemical behavior of MC-29 virus-induced transplantable chicken hepatoma, J. Toxicol. Environ. Health 5, 503-508 (1979).
5. G. TRICOT, H. N. JAYARAM, E. LAPIS, Y. NATSUMEDA, Y. YAMADA, C. R. NICHOLS, P. KNEEBONE, N. HEEREMA, G. WEBER and R. HOFFMAN, Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase activity, Cancer Res. 49, 3696-3701 (1989).
6. G. TRICOT, H. N. JAYARAM, G. WEBER and R. HOFFMAN, Tiazofurin: biological effects and clinical uses, Intl. J. Cell Cloning 8, 161-170 (1990).
7. G. WEBER, N. PRAJDA, M. ABONYI, K. Y. LOOK and G. TRICOT, Tiazofurin: molecular and clinical action, Anticancer Res. 16, 3313-3322 (1996).
8. M. S. LUI, M. A. FADERAN, J. J. LIEPNICKS, Y. NATSUMEDA, E. OLAH, H. N. JAYARAM and G. WEBER, Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide), J. Biol. Chem. 259, 5078-5082 (1984).
9. G. WEBER, F. SHEN, N. PRAJDA, H. YANG, W. LI, A. YEH, B. CSOKAY, E. OLAH and K. Y. LOOK, Regulation of the signal transduction program by drugs, Advan. Enzyme Regul. 37, 35-55 (1997).
10. F. SHEN and G. WEBER, Synergistic action of quercetin and genistein in human ovarian carcinoma cells, Oncol. Res. 9, 597-602 (1997).
11. W. LI and G. WEBER, Synergistic action of tiazofurin and genistein on growth inhibition and differentiation of K-562 human leukemic cells, Life Sci. 63, 1975-1981 (1998).
12. H. YANG, F. SHEN, M. HERENYIOVA and G. WEBER, Phospholipase C (EC 3.1.4.11): A malignancy linked signal transduction enzyme, Anticancer Res. 18, 1399-1404 (1998).
13. P. D. ROACH and F. B. PALMER, Human erythrocyte cytosol phosphatidyl-inositol-bisphosphate phosphatase, Biochim. Biophys. Acta 661, 323-333 (1981).
14. M. MATZARIS, S. P. JACKSON, K. M. LAXMINARAYAN, C. J. SPEED and C. A. MITCHELL, Identification and characterization of the phosphatidylinositol-(4,5)-bisphosphate 5-phosphatase in human platelets, J. Biol. Chem. 269, 3397-3402 (1994).
15. R. L. SINGHAL, N. PRAJDA, Y. A. YEH and G. WEBER, 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme, Cancer Res. 54, 5574-5578 (1994).
16. J. L. WEBB, Enzyme and Metabolic Inhibitors, Academic Press, New York 1, 507-510 (1963).
17. T.-C. CHOU and P. TALALAY, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Advan. Enzyme Regul. 22, 27-55 (1984).
18. M. T. RIZZO and G. WEBER, 1-Phosphatidylinositol 4-kinase: an enzyme linked with proliferation and malignancy, Cancer Res. 54, 2611-2614 (1994).
19. R. L. SINGHAL, Y. A. YEH, K. Y. LOOK, G. W. SLEDGE JR. and G. WEBER, Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells, Life Sci. 55, 1487-1492 (1994).
20. G. WEBER, N. PRAJDA, H. YANG, Y. A. YEH, F. SHEN, R. L. SINGHAL, M. HERENYIOVA and K. Y. LOOK, Current issues in the regulation of signal transduction, Advan. Enzyme Regul. 36, 33-55 (1996).
21. G. WEBER, R. L. SINGHAL, N. PRAJDA, Y. A. YEH, K. Y. LOOK and G. W. SLEDGE JR., Regulation of signal transduction, Advan. Enzyme Regul. 35, 1-21 (1995).
22. N. PRAJDA, R. L. SINGHAL, Y. A. YEH, E. OLAH, K. Y. LOOK and G. WEBER, Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin, Life Sci. 56, 1587-1593 (1995).
23. L. MANZOLI, A. M. BILLI, R. S. GILMOUR, A. M. MARTELLI, A. MATTEUCCI, S. RUBBINI, G. WEBER and L. COCCO, Phosphoinositide signaling in nuclei of Friend cells: tiazofurin down-regulates phospholipase C β1, Cancer Res. 55, 2978-2980 (1995).
24. H. A. KREBS, Considerations concerning the pathways of synthesis in living matter, Bull. Johns Hopkins Hosp. 95, 19-33 (1954).
25. D. G. WRIGHT, M. S. BOOSALIS, L. J. OSHRY and K. WARASKA, Tiazofurin effects on IMP dehydrogenase activity and expression in the leukemic cells of patients with CML blast crisis, Anticancer Res. 16, 3349-3354 (1996).
26. F. SHEN and G. WEBER, Tamoxifen down-regulates signal transduction and is synergistic with tiazofurin in human breast carcinoma MDA-MB-435 cells. Oncol. Res., 10, 325-331 (1998).
27. 1 phase, Cancer Res. 43, 3583-3585 (1983).
28. E. OLAH, Y. NATSUMEDA, T. IKEGAMI, Z. KOTE, M. HORANI, J. SZELENYI, E. PAULIK, T. KREMMER, S. R. HOLLAN, J. SUGAR and G. WEBER, Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells, Proc. Natl. Acad. Sci., U.S.A. 85, 6533-6537 (1988).
29. E. OLAH, Z. KOTE, Y. NATSUMEDA, Y. YAMAJI, G. JARAI, E. LAPIS, I. FINANCSEK and G. WEBER, Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells, Cancer Biochem. Biophys. 11, 107-117 (1990).
30. G. WEBER, M. NAGAI, Y. NATSUMEDA, J. N. EBLE, H. N. JAYARAM, E. PAULIK, W. ZHEN, R. HOFFMAN and G. TRICOT, Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient, Cancer Commun. 3, 61-66 (1991).
31. H. ADLERCREUTZ, H. MARKKANEN and S. WATANABE, Plasma concentrations of phyto-oestrogens in Japanese men, Lancet 342, 1209-1210 (1993).
32. C. A. MITCHELL, S. BROWN, J. K. CAMPBELL, A. D. MUNDAY and C. J. SPEED, Regulation of second messengers by the inositol polyphosphate 5-phosphatases, Biochem. Soc. Transactions 24, 994-1000 (1996).